Mark Gillies

12PUBLICATIONS
49CO-AUTHORS
Optical technologyCardiovascular medicine and haematology not elsewhere classifiedVision scienceGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 04, 2026
Aflibercept 24-Month Outcomes in Diabetic Macular Edema With and Without Prior Macular Laser Therapy: Data from the Fight Retinal Blindness! Registry.

|May 13, 2026
Suspending vascular endothelial growth factor inhibitors in eyes with retinal vein occlusion.

|May 06, 2026
Outcomes of eyes with persistent diabetic macular oedema: The Fight Retinal Blindness! Project.

|Dec 18, 2025
TALON phase IIIb study: 64 week results of brolucizumab versus aflibercept using treat-and-extend for neovascular age-related macular degeneration.

Carl Regillo, Peter K Kaiser, Peter J Kertes

|Aug 28, 2025
Retinal Pigment Epithelium Transplantation in Retinal Disease: Clinical Trial Development, Challenges, and Future Directions.

Qin Chen, Ting Zhang, Zhi Chen

|Sep 21, 2024
Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study.

Martín Puzo, Pilar Calvo-Perez, Francisco Bartol-Puyal

Pageof 2

Frequent Collaborators

4 joint publications

Vuong Nguyen

3 joint publications

Daniel Barthelmes

2 joint publications

Javier Zarranz-Ventura

2 joint publications

Francesco Viola